By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
GMJ NewsGMJ NewsGMJ News
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Notification Show More
Font ResizerAa
GMJ NewsGMJ News
Font ResizerAa
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Follow US
GMJ News > Drugs A-Z > ACE inhibitor > Trandolapril

Trandolapril

GMJ
Last updated: 01/06/2026 20:19
By
GMJ News Desk
Share
6 Min Read
SHARE
4 min read|725 words

Trandolapril: Drug Profile

What is Trandolapril?

Trandolapril is a prescription medication belonging to a class of drugs called angiotensin-converting enzyme (ACE) inhibitors. It is primarily used to treat high blood pressure (hypertension) and heart failure by helping blood vessels relax and widen. This medication is taken orally and works by blocking certain enzymes that cause blood vessels to narrow.

Uses

Trandolapril is prescribed for several cardiovascular conditions:

  • High blood pressure (hypertension): Helps lower blood pressure by relaxing blood vessels, reducing the risk of stroke, heart attack, and kidney problems
  • Heart failure: Improves heart function and reduces symptoms in patients with reduced heart pumping ability
  • Post-heart attack protection: May be prescribed after a heart attack to prevent further cardiovascular events and improve survival
  • Diabetic kidney disease: Helps protect kidney function in patients with diabetes by reducing protein loss in urine
  • Cardiovascular risk reduction: Used in high-risk patients to prevent heart attacks, strokes, and other cardiovascular complications

How it works

Trandolapril blocks the action of angiotensin-converting enzyme (ACE), which normally converts angiotensin I to angiotensin II, a powerful substance that causes blood vessels to narrow and triggers the release of hormones that increase blood pressure. By inhibiting this enzyme, trandolapril allows blood vessels to remain relaxed and dilated, which lowers blood pressure and reduces the workload on the heart. This mechanism also helps improve blood flow to the kidneys and other organs.

Side effects

Common side effects:

Submit Your Paper
GMJ_Submit_Banner
  • Dry, persistent cough
  • Dizziness or lightheadedness
  • Fatigue or weakness
  • Headache
  • Nausea
  • Low blood pressure (hypotension)
  • Elevated potassium levels (hyperkalemia)
  • Decreased kidney function

Serious side effects requiring immediate medical attention:

  • Swelling of face, lips, tongue, or throat (angioedema)
  • Severe kidney problems or kidney failure
  • Dangerously high potassium levels causing heart rhythm problems
  • Severe drop in blood pressure causing fainting
  • Liver problems with yellowing of skin or eyes

Warnings and precautions

  • Pregnancy: Trandolapril is contraindicated during pregnancy as it can cause serious harm to the developing fetus, including kidney problems, low blood pressure, and death. Women should use effective contraception while taking this medication.
  • Kidney disease: Patients with existing kidney problems require careful monitoring as ACE inhibitors can worsen kidney function, especially in those with severe kidney disease or bilateral renal artery stenosis.
  • High potassium levels: Regular blood tests are needed to monitor potassium levels, as trandolapril can cause dangerous elevations, particularly in patients with kidney disease or diabetes.
  • Surgery and anesthesia: Patients should inform their healthcare providers about trandolapril use before any surgical procedures, as it may interact with anesthesia and cause severe low blood pressure.
  • Dehydration: Patients should maintain adequate fluid intake and avoid situations that may cause dehydration, as this can lead to dangerous drops in blood pressure.

Interactions

  • Potassium supplements and salt substitutes: Can cause dangerous elevations in blood potassium levels when combined with trandolapril
  • Diuretics (water pills): May cause excessive blood pressure lowering, especially when starting treatment
  • NSAIDs (ibuprofen, naproxen): Can reduce the effectiveness of trandolapril and increase the risk of kidney problems
  • Lithium: Trandolapril can increase lithium levels in the blood, potentially leading to lithium toxicity
  • Diabetes medications: ACE inhibitors may enhance the blood sugar-lowering effects of diabetes drugs, increasing the risk of hypoglycemia
  • Other blood pressure medications: Combined use may cause excessive blood pressure reduction requiring dose adjustments
  • Aliskiren: Should not be used together in patients with diabetes or kidney disease due to increased risk of kidney problems and high potassium
  • Gold injections: May cause severe reactions including flushing, nausea, and dangerously low blood pressure

Check interactions with the GMJ Interaction Checker

Dosage

Typical adult dosages for trandolapril vary based on the condition being treated. For hypertension, the usual starting dose is 1-2 mg once daily, which may be increased gradually to a maximum of 8 mg daily based on blood pressure response. For heart failure, treatment typically begins with 1 mg once daily, with gradual increases up to 4 mg daily as tolerated. Patients with kidney impairment may require lower starting doses. Dosage adjustments should always be made under medical supervision, with regular monitoring of blood pressure, kidney function, and potassium levels. Healthcare providers will determine the most appropriate dose based on individual patient factors, response to treatment, and concurrent medications.

Sources: FDA DailyMed drug labels (public domain), BNF, WHO Essential Medicines List. This article is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before starting or stopping any medication.

Cite this page

GMJ News Desk. "Trandolapril." GMJ News — Georgian Medical Journal, 1 June 2026. https://news.gmj.ge/drug/trandolapril/

CC BY 4.0This work is licensed under Creative Commons Attribution 4.0 International (CC BY 4.0). You are free to share and adapt this content with attribution to GMJ News (news.gmj.ge).

Was this article helpful?

Share This Article
Facebook LinkedIn Bluesky Copy Link Print

Submit Your Paper →

Georgia's peer-reviewed open-access medical journal. No APC until January 2027.
Submit Manuscript →
Endometriosis Affects 10% of Women Yet Faces Chronic Under-recognition, BBC Investigation Reveals

BBC investigation reveals endometriosis affects 10% of women yet faces chronic under-recognition,…

Medical School Diversity Gains Not Translating to Diverse Physician Workforce

Despite medical schools successfully diversifying enrollment, these gains aren't translating to physician…

Maternity Staff Used Offensive Terms for Patients, BBC Investigation Reveals

BBC Panorama investigation reveals maternity staff at Nottingham University Hospitals NHS Trust…

Submit Your Paper to GMJ

No APC until January 2027.
Submit Manuscript →

You Might Also Like

Benazepril

By
GMJ News Desk
01/06/2026

Captopril

By
GMJ News Desk
01/06/2026

Enalapril

By
GMJ News Desk
01/06/2026

Captopril

By
GMJ News Desk
01/06/2026
Facebook Twitter Youtube Instagram
Company
  • Privacy Policy
  • Contact US
  • GMJ Journal
  • Submit Manuscript
  • Editorial Team
  • Register at GMJ
  • Terms of Use

Subscribe to GMJ News — Click here

Join Community
© 2026 Georgian Medical Journal (GMJ). Published by the Public Health Institute of Georgia (PHIG). All rights reserved.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?

Not a member? Sign Up